Sastasundar Ventures Share Price Today | Stock Price & Sastasundar Ventures Share Screener
As of April 28, 2026, the live Sastasundar Ventures share price (NSE: SASTASUNDR) is ₹272.10 on NSE and ₹276.90 on BSE, up 0.48% from the previous close, with shares trading between ₹268.40 and ₹277.00 in today's trading session, and a 52-week range of ₹256.95–₹329.95. Check SASTASUNDR 52-week high low for the annual price range and momentum. Use the Sastasundar Ventures stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sastasundar Ventures opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹308 and net income of ₹18, with EBITDA of ₹-3, an operating margin of -9.0% and a profit margin of 5.8%.
Sastasundar Ventures Share Price Chart
Track the current stock price of Sastasundar Ventures with an interactive chart. Analyse SASTASUNDR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sastasundar Ventures stock quote in one place.
The quote of ₹272.10 sits between the 52-week low of ₹256.95 and the 52-week high of ₹329.95, and the latest session moved 0.48% from the previous close.
Sastasundar Ventures Company Profile - Fundamental Screener
Screen Sastasundar Ventures company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SASTASUNDR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE019J01013.
Company Details
Classification
Identifiers and Leadership
Sastasundar Ventures Balance Sheet Screener
Screen SASTASUNDR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹974, down from ₹1,150 in 2024.
Latest statistics put total assets at ₹974 and shareholder funds at ₹865.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 974 | 1,150 | 1,206 | 1,278 | 293 | 316 | 231 | 236 | 251 | 256 |
| Current Assets | 267 | 354 | 575 | 508 | 131 | 137 | 66 | 95 | 108 | 90 |
| Fixed Assets | 102 | 110 | 107 | 93 | 110 | 114 | 116 | 117 | 125 | 126 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 5 | 72 | 102 | 116 | 3 | 3 | 8 | 5 | 7 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 865 | 1,000 | 994 | 1,094 | 229 | 246 | 200 | 203 | 195 | 218 |
| Share Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves & Surplus | 638 | 726 | 717 | 790 | 163 | 173 | 106 | 144 | 158 | 186 |
Sastasundar Ventures Income Statement Screener - Profit & Revenue Analysis
Screen Sastasundar Ventures income statement and profit fundamentals. Analyze SASTASUNDR quarterly results. Sastasundar Ventures reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2025-Mar, revenue was ₹308 and net profit was ₹18, equal to earnings per unit of ₹4.30, at an operating margin of -9%.
In that period expenses were ₹311, interest cost ₹0 and tax ₹-22. The next period listed, 2025-Jun, shows revenue of ₹324 and net profit of ₹27.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 308 | 324 | 307 | 359 | 325 | 299 | 296 | 270 | 322 | 348 | 368 | 395 | 161 | 197 | 260 |
| Expenses | 311 | 292 | 324 | 356 | 317 | 273 | 468 | 307 | 324 | 327 | 355 | 371 | 194 | 222 | 269 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | -3 | 31 | -17 | 3 | 8 | 26 | -172 | -38 | -3 | 21 | 13 | 24 | -33 | -25 | -8 |
| Operating Profit % | -9.00% | 2.00% | -8.00% | -3.00% | -3.00% | -1.00% | -71.00% | -9.00% | -4.00% | 3.00% | 1.00% | 1.00% | -24.00% | -16.00% | -6.00% |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -5 | 30 | -19 | 1 | 5 | 25 | -174 | -39 | -6 | 19 | 11 | 21 | -34 | -26 | -11 |
| Tax | -22 | 4 | -3 | 1 | -17 | -16 | -19 | -1 | 42 | 19 | 23 | 24 | -8 | -1 | -8 |
| Net Profit | 18 | 27 | -15 | 0 | 22 | 41 | -155 | -38 | -48 | 0 | -12 | -3 | -26 | -25 | -3 |
| EPS | 4.30 | 7.52 | -3.99 | 0.35 | 5.17 | 9.79 | -34.40 | -8.47 | -10.75 | 0.41 | -2.55 | -0.23 | -6.07 | -6.24 | -0.39 |
Sastasundar Ventures Cash Flow Screener - Liquidity Fundamentals
Screen SASTASUNDR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities used ₹17, and net cash flow was an outflow of ₹19.
Over the same period, investing activities used ₹1 and financing activities provided ₹0.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -17 | 36 | -112 | -207 | -31 | -69 | -30 | -49 | -2 | -12 |
| Investing Activities | -1 | -34 | 133 | 220 | 21 | -22 | -2 | 15 | 4 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | -2 | -2 | -11 | 4 | 103 | 26 | 33 | 5 | 13 |
| Net Cash Flow | -19 | 0 | 19 | 1 | -5 | 11 | -6 | -2 | 7 | 0 |
Sastasundar Ventures Shareholding Pattern Screener
See Sastasundar Ventures shareholding pattern with promoter, FII, and DII holdings. Check Sastasundar Ventures promoter holding and ownership changes for SASTASUNDR on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 74.84%, foreign institutions 2.17%, domestic institutions 2.60% and the public 12.25%, spread across 11,845 shareholders.
The shareholder count was 11,845 in 2026-Mar, compared with 13,693 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 74.84% | 74.11% | 74.24% | 74.24% | 74.69% | 73.92% | 73.92% | 73.92% |
Institutional Investors | ||||||||
| FII Holding | 2.17% | 1.60% | 1.88% | 2.04% | 2.25% | 0.56% | 0.61% | 0.99% |
| DII Holding | 2.60% | 2.06% | 2.09% | 2.07% | 2.07% | 0.96% | 1.35% | 1.98% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.25% | 13.70% | 13.35% | 12.84% | 12.72% | 16.06% | 15.05% | 14.47% |
| Other Holding | 8.15% | 8.52% | 8.44% | 8.81% | 8.27% | 8.51% | 9.07% | 8.63% |
| Shareholder Count | 11,845 | 13,693 | 13,452 | 13,012 | 12,287 | 14,544 | 14,493 | 15,360 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sastasundar Ventures. Sastasundar Ventures dividend yield can be compared with peers and other stocks in the market.
Sastasundar Ventures Stock Index Membership - Nifty & Sensex
See which indices include Sastasundar Ventures stock. Check SASTASUNDR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 2 indices, including BSE INDEX BSE HC.
Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Sastasundar Ventures Market Events Screener - Corporate Actions
Get Sastasundar Ventures corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sastasundar Ventures stock events that may affect SASTASUNDR share price, along with derivatives, futures and options activity and sector gainers.
9 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Change Of Name dated .
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 13.20% | ||
| Annual General Meeting | NA | -0.45% | ||
| Change Of Name | NA | - | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -0.48% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.01% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 2.90% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.65% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -2.60% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.70% |
Sastasundar Ventures Competitors Screener - Peer Stocks Comparison
Screen SASTASUNDR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,654 | 44.48 | 2,555 | 11.28% | 492 | 53.73 |
| Vijaya Diagnostic Centre | 11,426 | 71.46 | 700 | 23.06% | 144 | 78.69 |
| Metropolis Healthcare | 9,969 | 58.41 | 1,346 | 10.64% | 146 | 59.43 |
| Thyrocare Technologies | 6,472 | 48.41 | 702 | 20.80% | 91 | 60.53 |
| Nephrocare Health Services | 5,414 | 75.75 | 770 | 33.97% | 67 | 47.12 |
| Krsnaa Diagnostics | 1,913 | 24.22 | 743 | 16.70% | 78 | 45.59 |
| Suraksha Diagnostic | 1,475 | 45.69 | 256 | 15.11% | 31 | 61.55 |
| 3B BlackBio DX | 1,125 | 19.14 | 112 | 28.72% | 48 | |
| One Global Service Provider | 1,044 | 16.90 | 148 | 134.60% | 19 | 43.39 |
| Sastasundar Ventures | 866 | 29.62 | 1,171 | -18.47% | -134 | 48.71 |
Sastasundar Ventures Company Announcements - News & Reports Screener
Screen SASTASUNDR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated May 1, 2026.
The next most recent announcements are dated April 30, 2026 and April 6, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-05-01 | Approval From Stock Exchange For Change In Name And Symbol | - |
| 2026-04-30 | Update On Application To Stock Exchanges For Change In Name Of The Company | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-01 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-27 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-03-23 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-19 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-16 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-13 | Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015 | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-27 | Disclosure under Regulation 30A of LODR | - |
| 2026-02-27 | Disclosure Under Reg 30(9) Of SEBI (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board Meeting | - |
| 2026-02-27 | Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of Directors | - |
| 2026-02-26 | Disclosure Under Reg 30 (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board Meeting | - |
| 2026-02-26 | Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of Directors | - |
| 2026-02-25 | Disclosure Under Reg 30 Of SEBI (LODR) Reg - Execution Of Share Purchase Agreement By Sastasundar Healthbuddy Limited Material Subsidiary Of The Company | - |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Change of Company Name | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹272.10, within a 52-week range of ₹256.95 to ₹329.95. The P/E ratio is 29.62 and the P/B ratio is 1.27, with earnings per unit of ₹-28.66. Market capitalisation stands at ₹865.56 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on May 4, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.